Fideicomiso Irrevocable F/2061 FHipo
BNZIF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $8,489 | $6,763 | $20,782 | $16,905 |
| % Growth | 25.5% | -67.5% | 22.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $40 |
| Gross Profit | $8,489 | $6,763 | $20,782 | $16,866 |
| % Margin | 100% | 100% | 100% | 99.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $5,754 | $4,957 | $5,262 | $0 |
| SG&A Expenses | $5,754 | $4,957 | $5,262 | -$138 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $108 | -$2,913 | $37,828 | $0 |
| Operating Expenses | $5,862 | $2,044 | $43,090 | -$138 |
| Operating Income | $10,397 | $4,719 | -$22,308 | $17,004 |
| % Margin | 122.5% | 69.8% | -107.3% | 100.6% |
| Other Income/Exp. Net | $0 | -$7,258 | $0 | -$8,139 |
| Pre-Tax Income | $2,628 | $4,719 | $2,326 | $8,865 |
| Tax Expense | $81 | $17 | $183 | $43 |
| Net Income | $2,547 | $4,702 | $2,509 | $8,821 |
| % Margin | 30% | 69.5% | 12.1% | 52.2% |
| EPS | 0.007 | 0.013 | 0.007 | 0.038 |
| % Growth | -46% | 88.1% | -82.6% | – |
| EPS Diluted | 0.007 | 0.013 | 0.007 | 0.038 |
| Weighted Avg Shares Out | 373,353 | 18,224 | 373,351 | 229,966 |
| Weighted Avg Shares Out Dil | 373,350 | 18,224 | 373,350 | 229,966 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $59 | $75 | $0 | $40 |
| EBITDA | $10,456 | $12,048 | $0 | $17,043 |
| % Margin | 123.2% | 178.1% | 0% | 100.8% |